Osteoarthritis, Knee
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals of both sexes. Age between 50 and 74 years old. Diagnosis of symptomatic knee osteoarthritis. Minimum pain intensity of 3 on the Visual Analog Scale (VAS). Meet the classification criteria of the American College of Rheumatology, including: joint pain; functional changes; presence of crepitus in the knee; joint stiffness lasting an average of 30 minutes; presence of osteophytes identified by imaging studies. Pain and functional disability in the knee for at least 3 months. Radiographic classification between grades 2 and 4 on the Kellgren–Lawrence scale
Exclusion criteria
Exclusion criteria: Individuals with the following complications: neoplasms; dementia; neurological deficits (sensory or motor); uncontrolled systemic arterial hypertension; patients using antidepressants; or who had acute infections; vascular complications; epilepsy; gravid uterus; burns as well as patients using pacemakers and patients using anti-inflammatory or analgesic medications; symptomatic hip OA; acute diseases; other rheumatic diseases; systemic or orthopedic that could interfere with the results and the performance of the tests; all these cases were excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: Pain reduction is expected in patients with knee osteoarthritis after photobiomodulation;Outcome 1: Significant decrease in the pain scale reported by patients compared to the initial state (pre-treatment) and/or in relation to the control and placebo groups. Improvement in functionality in the low-level laser group | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 2: It is expected that there will be a reduction in knee temperature, a reduction in TUG test walking time and an improvement in the functionality and quality of life of patients after photobiomodulation;Outcome found 2: There was no change in knee temperature, but there was a reduction in the walking time of the TUG test and an improvement in the functionality and quality of life of patients after photobiomodulation | — |
Countries
Brazil
Contacts
Instituto de Saúde e Biotecnologia da Universidade Federal do Amazonas